Chamath De Silva

Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance)

E. Perez, H. Linden, M. Goetz, 2021, Breast Cancer Research and Treatment.